Medincell shares dive 15% as FY26 loss widens, AbbVie trial delayed

Markets Investing.com By Investing.com 17 Jun 2026 09:31 1 min read

Medincell shares dive 15% as FY26 loss widens, AbbVie trial delayed

Medincell shares dive 15% as FY26 loss widens, AbbVie trial delayed

Medincell shares dive 15% as FY26 loss widens, AbbVie trial delayed

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.